Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC dental amalgam consultation

This article was originally published in Clinica

Executive Summary

The European Commission has launched a consultation process on dental amalgam and alternative dental restoration materials that will run until February 22. The consultation invited comments on two scientific opinions on dental amalgam and alternatives: the first is a report from the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) adopted on November 29 2007; and the second is a report by the Scientific Committee on Health and Environmental Risks (SCHER), adopted on November 29 2007. For further details about the essential findings of these reports, see: http://ec.europa.eu/dgs/health-consumer/dyna/enews.cfm?al-id=681

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel